TiGenix: Positive Phase IIa Study Results in Refractory Rheumatoid Arthritis With Allogeneic Stem Cell Product Cx611
4/22/2013 12:04:28 PM
More...
|
TiGenix Reports Full Year 2012 Financial Results
3/12/2013 9:01:46 AM
More...
|
TiGenix to Obtain National Reimbursement in Spain for Its Innovative Cartilage Therapy ChondroCelect®
3/12/2013 8:45:29 AM
More...
|
TiGenix: Presenting at 15th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference
2/13/2013 10:39:52 AM
More...
|
TiGenix: to Present at Key Conferences H1 2013
2/4/2013 9:25:36 AM
More...
|
TiGenix Successfully Renews GMP License for Stem Cell Manufacturing Facility in Madrid
1/29/2013 9:27:16 AM
More...
|
TiGenix: Positive Interim Safety Results of Phase IIa Rheumatoid Arthritis Study With Allogeneic Adult Stem Cells
12/19/2012 7:25:49 AM
More...
|
BioLife Solutions, Inc. (BLFS.OB) Announces TiGenix's Completion of Stem Cells and HypoThermosol® Clinical Trial
12/12/2012 9:16:11 AM
More...
|
TiGenix Signs Agreement for Commercialization of ChondroCelect in the Middle East
11/13/2012 11:26:20 AM
More...
|
TiGenix: Business Update & Financial Highlights for Q3 of 2012
11/8/2012 9:05:53 AM
More...
|
|